These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16217102)

  • 21. Adderall.
    Med Lett Drugs Ther; 2005 Mar; 47(1205):28. PubMed ID: 15795685
    [No Abstract]   [Full Text] [Related]  

  • 22. Medications for adolescents with attention-deficit/hyperactivity disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2008 Aug; 19(2):254-67, viii-ix. PubMed ID: 18822831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.
    Young J
    Adolesc Med State Art Rev; 2008 Aug; 19(2):216-28, vii. PubMed ID: 18822828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suggestions for improving intimacy in couples in which one partner has attention-deficit/ hyperactivity disorder.
    Betchen SJ
    J Sex Marital Ther; 2003; 29(2):103-24. PubMed ID: 12623763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effect of amphetaminil on enuresis nocturna primaria in children with hyperkinetic syndrome.
    Drtílková I; Misurec J; Balastíková B
    Homeost Health Dis; 1991; 33(5-6):288. PubMed ID: 18265500
    [No Abstract]   [Full Text] [Related]  

  • 26. ADHD black box warning: how concerned should we be?
    Cruz R; Kutscher EC
    S D Med; 2007 Feb; 60(2):63, 65. PubMed ID: 17390569
    [No Abstract]   [Full Text] [Related]  

  • 27. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 29. Amphetamine salt compound treatment for adults with attention deficit hyperactivity disorder.
    Newcorn JH
    Curr Psychiatry Rep; 2002 Apr; 4(2):85-6. PubMed ID: 11914167
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.
    Kollins SH; March JS
    Biol Psychiatry; 2007 Nov; 62(9):951-3. PubMed ID: 17950067
    [No Abstract]   [Full Text] [Related]  

  • 31. Conclusions inconsistent with results with amphetamines and divalproex.
    Kruszewski SP; Paczynski R
    Am J Psychiatry; 2005 Nov; 162(11):2197; author reply 2197-8. PubMed ID: 16263875
    [No Abstract]   [Full Text] [Related]  

  • 32. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention-Deficit Hyperactivity Disorder.
    DuPont RL
    Essent Psychopharmacol; 2005; 6(5):iv. PubMed ID: 16222908
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemorrhagic stroke in a patient recently started on mixed amphetamine salts.
    Kapetanovic S; Kim MA
    Am J Psychiatry; 2010 Oct; 167(10):1277-8. PubMed ID: 20889668
    [No Abstract]   [Full Text] [Related]  

  • 35. Age-related changes in motor subtle signs among girls and boys with ADHD.
    Poulton A; Nanan R
    Neurology; 2009 Oct; 73(15):1248; author reply 1248-9. PubMed ID: 19822879
    [No Abstract]   [Full Text] [Related]  

  • 36. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medication for ADHD and the risk of cardiovascular mortality].
    Kalverdijk LJ; Buitelaar JK; van der Gaag RJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2283-4; author reply 2284. PubMed ID: 17078147
    [No Abstract]   [Full Text] [Related]  

  • 39. Addictive drugs still best option for attention deficit disorder.
    Basu P
    Nat Med; 2006 Apr; 12(4):374. PubMed ID: 16598272
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to 'Psychostimulants, adult attention deficit hyperactivity disorder and morbid jealousy'.
    Paterson R
    Aust N Z J Psychiatry; 2000 Oct; 34(5):874-5. PubMed ID: 11037381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.